Return-path: Envelope-to: sales_marketing@ferozsons-labs.com Delivery-date: Tue, 24 Jun 2014 07:56:31 -0700 Received: from [119.154.176.198] (port=50423 helo=Khurramshahzad) by advanced644.inmotionhosting.com with esmtpa (Exim 4.82) (envelope-from ) id 1WzS7m-0001Yh-9g; Tue, 24 Jun 2014 07:55:58 -0700 From: "khurram shahzad" To: "'Dr. Sohail Manzoor'" , References: <48355B17-F5F9-42F6-8370-1CCD7CD2BA38@yahoo.com> In-Reply-To: <48355B17-F5F9-42F6-8370-1CCD7CD2BA38@yahoo.com> Subject: RE: Ferozsons lbs. signs agreement with Gilead sciences .... aap sab ku mubarik hu Date: Tue, 24 Jun 2014 19:54:48 +0500 Message-ID: <002101cf8fbc$48c38330$da4a8990$@shahzad@bfbio.com> MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_NextPart_000_0022_01CF8FE6.31998B30" X-Mailer: Microsoft Office Outlook 12.0 Thread-Index: Ac+PfYapou0oRbzcQoSn2vSVT/5sdwAPlpBQ Content-Language: en-us x-cr-hashedpuzzle: A3S/ DET4 DgH6 E5aC F6SO HLkk HvmT IIDw JUNT KuCk Kzxz OEDV R1ai TdZ7 VCYm W4FN;2;cwBhAGwAZQBzAF8AbQBhAHIAawBlAHQAaQBuAGcAQABmAGUAcgBvAHoAcwBvAG4AcwAtAGwAYQBiAHMALgBjAG8AbQA7AHMAbwBoAGEAaQBsAG0AYQBuAHoAbwBvAHIAQAB5AGEAaABvAG8ALgBjAG8AbQA=;Sosha1_v1;7;{3D93415E-79F7-4E93-9786-116A5FC56AD2};awBoAHUAcgByAGEAbQAuAHMAaABhAGgAegBhAGQAQABiAGYAYgBpAG8ALgBjAG8AbQA=;Tue, 24 Jun 2014 14:54:44 GMT;UgBFADoAIABGAGUAcgBvAHoAcwBvAG4AcwAgAGwAYgBzAC4AIABzAGkAZwBuAHMAIABhAGcAcgBlAGUAbQBlAG4AdAAgAHcAaQB0AGgAIABHAGkAbABlAGEAZAAgAHMAYwBpAGUAbgBjAGUAcwAgAC4ALgAuAC4AIABhAGEAcAAgAHMAYQBiACAAawB1ACAAbQB1AGIAYQByAGkAawAgAGgAdQA= x-cr-puzzleid: {3D93415E-79F7-4E93-9786-116A5FC56AD2} X-OutGoing-Spam-Status: No, score=1.6 This is a multipart message in MIME format. ------=_NextPart_000_0022_01CF8FE6.31998B30 Content-Type: multipart/alternative; boundary="----=_NextPart_001_0023_01CF8FE6.31998B30" ------=_NextPart_001_0023_01CF8FE6.31998B30 Content-Type: text/plain; charset="us-ascii" Content-Transfer-Encoding: 7bit Congrats to all Ferozsons Family. Its beginning of a new era. Best Regards, Khurram Shahzad HM Gujranwala From: Dr. Sohail Manzoor [mailto:sohailmanzoor@yahoo.com] Sent: Tuesday, June 24, 2014 12:26 PM To: sales_marketing@ferozsons-labs.com Subject: Ferozsons lbs. signs agreement with Gilead sciences .... aap sab ku mubarik hu Tue, Jun 24, 2014, Shaban 25,1435 A.H : Last updated 1 hour ago Image removed by sender. The News Advance Search Today's Paper | Archive | e-Paper Group Chairman: Mir Javed Rahman Image removed by sender. thenews.com.pk Founded by: Mir Khalil-ur-Rahman Editor-in-Chief: Mir Shakil-ur-Rahman * Latest News> * PakistanImage removed by sender.Image removed by sender. * National * Islamabad * Karachi * Lahore * Peshawar * Quetta * Other Cities * World * Sports * BusinessImage removed by sender.Image removed by sender. * Forex * Bullion Rates * KSE Quotes * Weird * Entertainment * Health * Sci-Tech * Opinion Image removed by sender.Image removed by sender. * Editorial * Opinion * Newspost * Today's PaperImage removed by sender.Image removed by sender. * Top Story * Election 2013 - SP Report * National * World * Business * Sports * Islamabad * Karachi * Lahore * Peshawar * Aman Ki Asha * Instep Today * Blog * The News On Sunday * Money Matters * You * Us * Photos * Videos * Cartoons * Results * ArchiveImage removed by sender.Image removed by sender. * Back Issues * Opinion Archive * Writers Archive Hot Topics NWA Operation Image removed by sender. Musharraf Image removed by sender. Federal Budget 2014-15 Image removed by sender. Altaf Hussain Image removed by sender. Hamid Mir Image removed by sender. Jang/Geo Response to Allegations You are here: Home > Today's Paper > Business Image removed by sender. Image removed by sender. Business Ferozsons Lab, Gilead Sciences sign agreement Javed Mirza Friday, June 20, 2014 From Print Edition Image removed by sender.29 Image removed by sender.0 Image removed by sender.2 Image removed by sender.1 KARACHI: Ferozsons Laboratories Limited has entered into an agreement with Gilead Sciences to be its exclusive branded medicines business partner for Pakistan, officials said on Thursday. Under the agreement, Ferozsons will market and distribute certain Gilead medications for the treatment of chronic Hepatitis-C; HIV and chronic Hepatitis-B virus (HBV) infection in Pakistan, the officials said. Osman Khalid Waheed, president of Ferozsons Laboratories Limited, said: "The agreement is a very important milestone for the company but more significantly it also marks a paradigm shift in the treatment landscape for diseases such as Hepatitis C, which affects over 10 million people in the country. We look forward to bringing these new innovations to patients in Pakistan." Stribild and Sovaldi are pending registration in Pakistan. The registration application for Sovaldi was submitted in May with the request for an accelerated review on the basis of medical needs, he said. In addition to distributing branded Gilead medicines, Ferozsons will manage regulatory and pharmaco-vigilance activities such as adverse event reporting, as well as broader medical education initiatives, he said. Sovaldi was approved in the United States on December 8, 2013 and in the European Union on January 17. In the United States, Sovaldi is approved for the treatment of chronic Hepatitis-C infection as a component of a combination antiviral treatment regimen. Stribild is a complete once-daily single tablet regimen for the treatment of HIV-1 infection. Truvada is a fixed-dose once-daily combination pill containing Viread and Emtriva. It is used in combination with other antiretroviral agents for the treatment of HIV infection in adults and pediatric patients 12 years of age and older, he said. Viread is a once-daily oral nucleotide reverse transcriptase inhibitor (NtRTI) for the treatment of HIV infection in patients two years of age and older in combination with other antiretroviral agents. Viread is also approved as a treatment for chronic Hepatitis-B in adults and pediatric patients 12 years of age and older. Viread is also indicated for the treatment of chronic Hepatitis-B virus (HBV) infection in adults. Gilead Sciences is an American biotechnology company that discovers, develops and commercialises therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, Hepatitis-B, or influenza. Ferozsons is the Pakistan's marketing and distribution partner for the Boston Scientific Corporation, US for its range of cardiac and peripheral products and interventional devices. Today's Newspaper Top story National World Business Sports Karachi Lahore Islamabad Peshawar Editorial Opinion Newspost Image removed by sender. More from Business Image removed by sender. 'Private chartered flights can earn up to $500m per annum' Image removed by sender. Foreigners encouraging local investment Image removed by sender. Nepra grants upfront tariff for wind projects Image removed by sender. Ten companies participate in SAITEX, AB7 Image removed by sender. KSE MD, DMD appeal against SECP penalty Image removed by sender. Car industry struggles to solve air bag explosions despite mass recalls Image removed by sender. 'IROs must be promoted to BPS-17' Image removed by sender. French politics trump business over Alstom Image removed by sender. IGI, Packages Group join hands Image removed by sender. Intel holds workshop Latest News . Sanaullah admits mismanagement caused Model Town tragedy Image removed by sender. . Khyber Agency: Jet fighter air strike kills 6 of the same family Image removed by sender. . More than 350 PAT workers booked Image removed by sender. . Lahore incident: Sana, Shah didn't appear before tribunal Image removed by sender. . SC overrules SHC order, Musharraf to stay on ECL Image removed by sender. . Afghan allegations termed baseless by Pakistan Image removed by sender. . 4 matches to be played today Image removed by sender. . Four-star Prasad stuns England in second Test Image removed by sender. . Messi turns 27 today Image removed by sender. . Last dangerous chemicals shipped from Syria: watchdog Image removed by sender. * Pakistan * World * Sports * Business * Weird * Technology * Entertainment * Video Gallery * Magazines * Facebook * Blog * Twitter * Google Plus * Photo Gallery * My City * Islamabad * Karachi * Lahore * Peshawar * Quetta * Other Cities * Print Edition * Editorial * Opinion * Newspost * Sports * National * Writers Archive * Contact Us * Classified * Viewers' Forum * How to Advertise * Opinion Archive * About Us * Feedback * RSS * Videos * E-Paper * Mobile * Back Issues * * Sitemap The News International - Copyright @ 2010-2012 Third-party Advertisement Policy |Privacy Policy | Contact Us Error! Filename not specified. Image removed by sender. Image removed by sender. Loading... Image removed by sender. Error! Filename not specified. Image removed by sender. Image removed by sender. ------=_NextPart_001_0023_01CF8FE6.31998B30 Content-Type: text/html; charset="us-ascii" Content-Transfer-Encoding: quoted-printable Ferozsons Lab, Gilead Sciences sign agreement - thenews.com.pk =

Congrats to all Ferozsons Family. Its beginning of a new = era.

 

Best Regards,

Khurram Shahzad

HM Gujranwala =

 

From:= Dr. Sohail = Manzoor [mailto:sohailmanzoor@yahoo.com]
Sent: Tuesday, June 24, 2014 12:26 PM
To: sales_marketing@ferozsons-labs.com
Subject: Ferozsons lbs. signs agreement with Gilead sciences .... = aap sab ku mubarik hu

 

3D"Image

 

3D"Image

 

 Business =

 

Ferozsons Lab, Gilead Sciences sign agreement =

 

 

Javed Mirza
Friday, June 20, 2014
From Print Edition

 

 

 3D"Image29  3D"Image0  3D"Image2  3D"Image1 =

 

 

KARACHI: Ferozsons Laboratories Limited has entered into an = agreement with Gilead Sciences to be its exclusive branded medicines business = partner for Pakistan, officials said on Thursday.

 

Under the agreement, Ferozsons will market and distribute certain = Gilead medications for the treatment of chronic Hepatitis-C; HIV and chronic Hepatitis-B virus (HBV) infection in Pakistan, the officials = said.

 

Osman Khalid Waheed, president of Ferozsons Laboratories Limited, = said: “The agreement is a very important milestone for the company but more = significantly it also marks a paradigm shift in the treatment landscape for diseases = such as Hepatitis C, which affects over 10 million people in the country. We = look forward to bringing these new innovations to patients in = Pakistan.”

 

Stribild and Sovaldi are pending registration in Pakistan. The = registration application for Sovaldi was submitted in May with the request for an accelerated review on the basis of medical needs, he = said.

 

In addition to distributing branded Gilead medicines, Ferozsons will = manage regulatory and pharmaco-vigilance activities such as adverse event = reporting, as well as broader medical education initiatives, he = said.

 

Sovaldi was approved in the United States on December 8, 2013 and in = the European Union on January 17. In the United States, Sovaldi is approved = for the treatment of chronic Hepatitis-C infection as a component of a = combination antiviral treatment regimen.

 

Stribild is a complete once-daily single tablet regimen for the = treatment of HIV-1 infection.

 

Truvada is a fixed-dose once-daily combination pill containing Viread = and Emtriva. It is used in combination with other antiretroviral agents for = the treatment of HIV infection in adults and pediatric patients 12 years of = age and older, he said.

 

Viread is a once-daily oral nucleotide reverse transcriptase = inhibitor (NtRTI) for the treatment of HIV infection in patients two years of age = and older in combination with other antiretroviral agents.

 

Viread is also approved as a treatment for chronic Hepatitis-B in = adults and pediatric patients 12 years of age and older. Viread is also indicated = for the treatment of chronic Hepatitis-B virus (HBV) infection in = adults.

 

Gilead Sciences is an American biotechnology company that discovers, develops and commercialises therapeutics. For many years since the = company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, Hepatitis-B, or influenza.

 

Ferozsons is the Pakistan’s marketing and distribution partner = for the Boston Scientific Corporation, US for its range of cardiac and = peripheral products and interventional devices.

 

 

 

 

 

More from = Business

 

3D"Image ‘Private chartered flights can = earn up to $500m per annum’

3D"Image Foreigners encouraging local = investment

3D"Image Nepra grants upfront tariff for wind = projects

3D"Image Ten companies participate in SAITEX, = AB7

3D"Image KSE MD, DMD appeal against SECP = penalty

3D"Image Car industry struggles to solve air = bag explosions despite mass recalls

3D"Image ‘IROs must be promoted to = BPS-17’

3D"Image French politics trump business over = Alstom

3D"Image IGI, Packages Group join = hands

3D"Image Intel holds workshop =

 

 

 

 

 

 

 

 

 

 

Error! Filename not = specified.

3D"Image

3D"Image

Error! Filename not = specified.

3D"Image

3D"Image

------=_NextPart_001_0023_01CF8FE6.31998B30-- ------=_NextPart_000_0022_01CF8FE6.31998B30 Content-Type: image/jpeg; name="~WRD000.jpg" Content-Transfer-Encoding: base64 Content-ID: <~WRD000.jpg> /9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a HBwgJC4nICIsIxwcKDcpLDAxNDQ0Hyc5PTgyPC4zNDL/2wBDAQkJCQwLDBgNDRgyIRwhMjIyMjIy MjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjL/wAARCABkAGQDASIA AhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQA AAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3 ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWm p6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEA AwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSEx BhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElK U1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3 uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3+iii gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKA CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo ooAKKKKACiiigAooooAKKKKACiiigD//2Q== ------=_NextPart_000_0022_01CF8FE6.31998B30 Content-Type: image/png; name="image001.png" Content-Transfer-Encoding: base64 Content-ID: iVBORw0KGgoAAAANSUhEUgAAAlIAAAAhCAMAAAAlKLUHAAAAAXNSR0ICQMB9xQAAAANQTFRFAAAA p3o92gAAAAF0Uk5TAEDm2GYAAAAJcEhZcwAADsQAAA7EAZUrDhsAAAAZdEVYdFNvZnR3YXJlAE1p Y3Jvc29mdCBPZmZpY2V/7TVxAAAAKklEQVR42u3BgQAAAADDoPlTn+AGVQEAAAAAAAAAAAAAAAAA AAAAAABcA0yzAAG2ZvDjAAAAAElFTkSuQmCC ------=_NextPart_000_0022_01CF8FE6.31998B30--